Welcome to the
NeurologyLive Mind Moments podcast. Tune in to hear leaders in neurology sound off on topics that impact your clinical practice.
In this episode, we spoke with Victor Sung, MD, director, UAB Huntington's Disease Clinic, codirector, UAB School of Medicine Neuroscience Module, and director, Birmingham VAMC Deep Brain Stimulation Program. Sung detailed data on the cost of genetic testing in HD that he and colleagues presented earlier this year at the International Parkinson and Movement Disorders Society Congress (MDS 2021), and the current utilization of testing in clinical practice.
Episode Breakdown:
1:45 – Background on the genetic testing process3:50 – Findings of the study presented at MDS 20217:30 – Future plans to evaluate genetic testing costs11:30 – Current utilization of genetic testing for HD14:10 – Neurology News Minute18:05 – Raising awareness for genetic testing 21:25 – Biggest step forward in Huntington disease25:10 – Takeaways from MDS 2021The stories featured in this week's Neurology News Minute, which will give you quick updates on the following developments in neurology, are further detailed here:
Cerezen Device Gets Breakthrough Designation in Alzheimer Disease, MCIEli Lilly Initiates Rolling Submission for Donanemab in Early Alzheimer DiseaseAmylyx Submits New Drug Application for ALS Treatment AMX0035
Thanks for listening to the NeurologyLive Mind Moments podcast. To support the show, be sure to rate, review, and subscribe wherever you listen to podcasts. For more neurology news and expert-driven content, visit neurologylive.com.
REFERENCE
Massey M, Orem T, Sung V. Cost of Predictive Genetic Testing for Huntington’s Disease at Centers of Excellence in the US. Presented at: MDS Congress 2021; September 17-22; Virtual. Poster 240.